Westminster, CA – November 15, 2018 – BioLargo, Inc.
(OTCQB:BLGO), developer of sustainable science and technologies and a
full-service environmental engineering company, today announced the filing of
its 10-Q quarterly report:
- Sales increased 147% for the nine months ended September 30, 2018, compared with the nine months ended September 30, 2017
- Monthly revenues exceeded expenses in the engineering division (BLEST) for the first time (in October)
- Two pre-commercial field pilot projects are underway for the company’s AOS clean water technology and two more are in final stages of preparation. These pilots represent a landmark in AOS development, as they will pave the way for future commercial trials and market launch
- Clyra Medical Technologies management met with the FDA in Washington DC to determine a clear pathway for clearance on its product submission under Section 510(k)
- Details on a series of completed bridge financing arrangements
- A Form S-1 that was filed with the SEC to pursue a public offering to raise capital to meet Nasdaq listing requirements that will be led by H.C. Wainwright & Co., LLC
The 10-Q quarterly report can be accessed here: LINK.
BioLargo President and CEO Dennis Calvert commented, “The
future is bright for BioLargo. Our disruptive odor and VOC control product
CupriDyne Clean represents our first significant commercial success that is
unfolding, and we believe our two other innovative technology platforms – Clyra
and the AOS – will follow in similar fashion soon. Our success with CupriDyne
Clean is an example of our business model succeeding. We leverage innovative
high-tech products that are meaningful in purpose and serve as cornerstones of
a commercial strategy. We combine them with services, value, talent and
partnerships to create a disruptive platform that wins market share. Our
engineering group, BLEST has been instrumental in our efforts to scale-up and
prepare for commercial readiness for our AOS clean water technology while at
the same time it has been building its outside services clients that now
include regional utilities, healthcare and Fortune 500 companies. We are
thankful for the continued support of our stockholders and believe 2019 will be
a great year.”
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and
environmental engineering company driven by a mission to "make life
better" by delivering robust, sustainable solutions for a broad range of
industries and applications, with a focus on clean water, clean air, and
advanced wound care. We develop and commercialize disruptive technologies by
providing the capital, support, and expertise to expedite them from
"cradle" to "maturity" (www.biolargo.com). Our engineering
division features experienced professional engineers dedicated to integrity,
reliability, and environmental stewardship (www.biolargoengineering.com). Our
industrial odor control division, Odor-No-More (www.odornomore.com) features
CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which
eliminates the odor-causing compounds and VOCs rather than masking them, and is
now winning over leading companies in the solid waste handling and wastewater
industries and other industries that contend with malodors and VOCs. Our
subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced
Oxidation System "AOS," a disruptive industrial water treatment
technology designed to eliminate waterborne pathogens and recalcitrant
contaminants with better energy-efficiency and lower operational costs than
incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com)
features effective and gentle solutions for chronic infected wounds to promote
infection control and regenerative tissue therapy.
Dennis Calvert President and CEO BioLargo, Inc. 949-643-9540
x2
Safe Harbor Act
This press release includes “forward-looking statements”
within the meaning of the safe harbor provisions of the United States Private
Securities Litigation Reform Act of 1995. Actual results may differ from
expectations, estimates and projections and, consequently, you should not rely
on these forward-looking statements as predictions of future events. Words such
as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,”
“intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,”
“potential,” “continue,” and similar expressions are intended to identify such
forward-looking statements. These forward-looking statements involve
significant risks and uncertainties that could cause the actual results to differ
materially from the expected results.
No comments:
Post a Comment